Showing 1,161 - 1,180 results of 2,085 for search '"Viral hepatitis"', query time: 0.12s Refine Results
  1. 1161

    ASSOCIATION BEETWEEN IL-28β POLYMORPHISMS AND EFFECTIVENESS OF CONCOMITANT THERAPY OF HIV INFECTION IN PATIENTS WITH HCV/HIV CO-INFECTION DURING THE ANTIVIRAL THERAPY by E. S. Kovaleva

    Published 2014-07-01
    “…It was concluded that rs8099917 polymorphism of the gene IL-28β affects the dynamics of the HIV RNA viral load in HIV-infected patients receiving concomitant therapy for treatment of viral hepatitis C. Herewith, rs8099917 polymorphism combined with other factors can be used as a predictor of high active antiretroviral therapy effectiveness.…”
    Get full text
    Article
  2. 1162
  3. 1163

    Hepatotropic medicines: current status by Sergey Vladimirovich Okovityy, Dmitriy Sergeevich Sukhanov, A Yu Petrov, Mikhail Grigor'evich Romantsov, S V Okovity, D S Sukhanov, A Yu Petrov, M G Romantsov

    Published 2012-02-01
    “…The above effectiveness and its antiasthenic and antidepressive activity makes this drug a universal hepatotropic medicine effective in various hepatic diseases (viral hepatitis C, toxic and pharmacological damage) both in therapeutic and prophylactic schemes.…”
    Get full text
    Article
  4. 1164

    Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy: a retrospective, observational study by Anika Franz, Philipp A Reuken, Sura Guliyeva, Michael Rose, Katharina Boden, Andreas Stallmach, Tony Bruns

    Published 2023-07-01
    “…Objective Hepatitis E virus (HEV) infections are common, self-limiting causes of acute viral hepatitis. This study aimed to analyze hepatic injury, viremia, and chronicity rates in patients with acute HEV infection receiving immunosuppressive (IS) therapy taking into account ribavirin treatment. …”
    Get full text
    Article
  5. 1165

    Autophagy modulates physiologic and adaptive response in the liver by Trinh Van Le, Nhung Hai Truong, Ai Xuan L. Holterman

    Published 2023-12-01
    “…This review summarizes how autophagy regulates epithelial cell- and non-epithelial cell-specific function in the liver and how it differentially participates in hepatic homeostasis, hepatic injury response to stress-induced liver damage such as cholestasis, sepsis, non-alcoholic and alcohol-associated liver disease, viral hepatitis, hepatic fibrosis, hepatocellular and cholangiocellular carcinoma, and aging. …”
    Get full text
    Article
  6. 1166

    Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review... by Di Carlo Isidoro, Mannino Maurizio, Toro Adriana, Ardiri Annalisa, Galia Antonio, Cappello Giovanni, Bertino Gaetano

    Published 2012-05-01
    “…This huge mass was diagnosed as HCC, arising in the absence of cirrhosis or viral hepatitis. After tumor removal, the patient’s high AFP level persisted for 2 years.…”
    Get full text
    Article
  7. 1167

    Non-AIDS-defining illnesses and causes of death in HIV-infected patients in St. Petersburg and Leningrad Region by Z. M. Zagdyn, G. V. Volkova, A. G. Rachmanova, A. Yu. Kovelenov, R. Heimer

    Published 2014-09-01
    “…HIV-infected patients mostly die from generalized tuberculosis and chronic viral hepatitis at the End-Stage liver cirrhosis. To properly evaluate the preavalnce of Non-HIV-related diseases and causes of death in HIV-infected people in St. …”
    Get full text
    Article
  8. 1168

    Occupational hazards to dental staff by Jamshid Ayatollahi, Fatemah Ayatollahi, Ali Mellat Ardekani, Rezvan Bahrololoomi, Jahangir Ayatollahi, Ali Ayatollahi, Mohammad Bagher Owlia

    Published 2012-01-01
    “…These include exposure to infections (including Human Immunodeficiency Virus and viral hepatitis); percutaneous exposure incidents, dental materials, radiation, and noise; musculoskeletal disorders; psychological problems and dermatitis; respiratory disorders; and eye insults. …”
    Get full text
    Article
  9. 1169

    Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. by Matthews, P, Geretti, A, Goulder, P, Klenerman, P

    Published 2014
    “…In high-income settings, the impact of antiretroviral therapy (ART) on survival has unmasked chronic liver disease from viral hepatitis B or hepatitis C as a leading cause of morbidity and mortality in individuals with HIV infection. …”
    Journal article
  10. 1170

    Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapy by Lumley, S, Barlow, M, Said, K, Martyn, E, Waddilove, E, Delphin, M, Jennings, D, Chai, H, Kemper, A, Ko, J, Ansari, A, Macdonald, D, Ghosh, I, Ijaz, S, Flanagan, S, Matthews, PC

    Published 2024
    “…Diagnosing and treating chronic hepatitis B virus (HBV) infection are key interventions to support progress towards elimination of viral hepatitis by 2030. Although nucleos/tide analogue (NA) therapy is typically highly effective, challenges remain for viral load (VL) suppression, including medication access, incomplete adherence and drug resistance. …”
    Journal article
  11. 1171

    3382 Assessing Racial Disparities in Hepatitis C Retention of Care by Austin Taylor Jones, Lisa Moreno-Walton, Kanayo R. Okeke-Eweni, Keanan M. McGonigle, David H. Yang, Morris Kim, Jenna Miller, Patricia Kissinger

    Published 2019-03-01
    “…AAs had attenuated odds of attending viral hepatitis specialty clinic (aOR=1.09, CI = 1.01-1.19). …”
    Get full text
    Article
  12. 1172
  13. 1173
  14. 1174
  15. 1175
  16. 1176
  17. 1177
  18. 1178
  19. 1179
  20. 1180